Sfoglia per Autore
Specific markers, micro-environmental anomalies and tropism: opportunities for gold nanorods targeting of tumors in laser-induced hyperthermia
2014-01-01 Tatini, F.; Ratto, F.; Centi, S.; Landini, I.; Nobili, S.; Witort, E.; Fusi, F.; Capaccioli, S.; Mini, E.; Pini, R.
Druggable targets in pancreatic adenocarcinoma
2014-01-01 Nobili, S.; Tassi, R.; Landini, I.; Perrone, G.; Napoli, C.; Mini, E.
In vitro study on the safety of near infrared laser therapy in its potential application as postmastectomy lymphedema treatment
2015-01-01 Cialdai, F.; Landini, I.; Capaccioli, S.; Nobili, S.; Mini, E.; Lulli, M.; Monici, M.
Emerging drugs in refractory colorectal cancer
2015-01-01 Nobili, S.; Galletta, A.; Brugia, M.; Tassi, R.; Petreni, P.; Landini, I.; Mini, E.
Editorial: Multidrug resistance in cancer: Pharmacological strategies from basic research to clinical issues
2015-01-01 Riganti, C.; Mini, E.; Nobili, S.
Chronic inflammation in urothelial bladder cancer
2015-01-01 Nesi, G.; Nobili, S.; Cai, T.; Caini, S.; Santi, R.
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin
2015-01-01 Cecchin, E.; Perrone, G.; Nobili, S.; Polesel, J.; De Mattia, E.; Zanusso, C.; Petreni, P.; Lonardi, S.; Pella, N.; D'Andrea, M.; Errante, D.; Rizzolio, F.; Mazzei, T.; Landini, I.; Mini, E.; Toffoli, G.
Proteomic analysis of the cytotoxic effects induced by the organogold(iii) complex Aubipyc in cisplatin-resistant A2780 ovarian cancer cells: further evidence for the glycolytic pathway implication
2015-01-01 Gamberi, T.; Magherini, F.; Fiaschi, T.; Landini, I.; Massai, L.; Valocchia, E.; Bianchi, L.; Bini, L.; Gabbiani, C.; Nobili, S.; Mini, E.; Messori, L.; Modesti, A.
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines
2015-01-01 Toffoli, G.; Giodini, L.; Buonadonna, A.; Berretta, M.; De Paoli, A.; Scalone, S.; Miolo, G.; Mini, E.; Nobili, S.; Lonardi, S.; Pella, N.; Lo Re, G.; Montico, M.; Roncato, R.; Dreussi, E.; Gagno, S.; Cecchin, E.
HLA-G 3'UTR polymorphisms impact the prognosis of stage II-III CRC patients in fluoropyrimidine-based treatment
2015-01-01 Garziera, M.; Bidoli, E.; Cecchin, E.; Mini, E.; Nobili, S.; Lonardi, S.; Buonadonna, A.; Errante, D.; Pella, N.; D'Andrea, M.; De Marchi, F.; De Paoli, A.; Zanusso, C.; De Mattia, E.; Tassi, R.; Toffoli, G.
Association of the HLA-G 3′UTR polymorphisms with colorectal cancer in Italy: A first insight
2016-01-01 Garziera, M.; Catamo, E.; Crovella, S.; Montico, M.; Cecchin, E.; Lonardi, S.; Mini, E.; Nobili, S.; Romanato, L.; Toffoli, G.
The inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on growth in human tumor cell lines with defective DNA damage response pathways
2017-01-01 Mini, E.; Landini, I.; Lucarini, L.; Lapucci, A.; Napoli, C.; Perrone, G.; Tassi, R.; Masini, E.; Moroni, F.; Nobili, S.
Selection and characterization of a human ovarian cancer cell line resistant to auranofin
2017-01-01 Landini, I.; Lapucci, A.; Pratesi, A.; Massai, L.; Napoli, C.; Perrone, G.; Pinzani, P.; Messori, L.; Mini, E.; Nobili, S.
DPYD gene activity score (GAS) predicts dose-limiting toxicity in fluoropyrimidine-treated colorectal cancer patients
2018-01-01 Dalle Fratte, Chiara; Polesel, Jerry; Roncato, Rossana; De Mattia, Elena; Ecca, Fabrizio; Bignucolo, Alessia; Garziera, Marica; Dreussi, Eva; Palazzari, Elisa; Buonadonna, Angela; Guardascione, Michela; Berretta, Massimiliano; Foltran, Luisa; Sartor, Franca; D’Andrea, Mario; Favaretto, Adolfo; Mini, Enrico; Nobili, Stefania; De Paoli, Antonino; Toffoli, Giuseppe; Cecchin, Erika
A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis
2018-01-01 Lavacchi, D.; Nobili, S.; Brugia, M.; Paderi, A.; Fancelli, S.; Caliman, E.; Vergoni, F.; Mini, E.
Snail immunohistochemical overexpression correlates to recurrence risk in non-muscle invasive bladder cancer: results from a longitudinal cohort study
2018-01-01 Santi, R.; Cai, T.; Nobili, S.; Galli, I. C.; Amorosi, A.; Comperat, E.; Nesi, G.
The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice
2018-01-01 Toffoli, Giuseppe; Innocenti, Federico; Polesel, Jerry; De Mattia, Elena; Sartor, Franca; Dalle Fratte, Chiara; Ecca, Fabrizio; Dreussi, Eva; Palazzari, Elisa; Guardascione, Michela; Buonadonna, Angela; Foltran, Luisa; Garziera, Marica; Bignucolo, Alessia; Nobili, Stefania; Mini, Enrico; Favaretto, Adolfo; Berretta, Massimiliano; D'Andrea, Mario; De Paoli, Antonino; Roncato, Rossana; Cecchin, Erika
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study
2018-01-01 Magherini, F.; Fiaschi, T.; Valocchia, E.; Becatti, M.; Pratesi, A.; Marzo, T.; Massai, L.; Gabbiani, C.; Landini, I.; Nobili, S.; Mini, E.; Messori, L.; Modesti, A.; Gamberi, T.
A clinical-genetic score to identify surgically resected colorectal cancer patients benefiting from an adjuvant fluoropyrimidine-based therapy
2018-01-01 De Mattia, E.; Dreussi, E.; Montico, M.; Gagno, S.; Zanusso, C.; Quartuccio, L.; De Vita, S.; Guardascione, M.; Buonadonna, A.; D'Andrea, M.; Pella, N.; Favaretto, A.; Mini, E.; Nobili, S.; Romanato, L.; Cecchin, E.; Toffoli, G.
Transcriptional subtyping and CD8 immunohistochemistry identifies patients with stage II and III colorectal cancer with poor prognosis who benefit from adjuvant chemotherapy
2018-01-01 Allen, W. L.; Dunne, P. D.; Mcdade, S.; Scanlon, E.; Loughrey, M.; Coleman, H. G.; Mccann, C.; Mclaughlin, K.; Nemeth, Z.; Syed, N. A.; Jithesh, P. V.; Arthur, K.; Wilson, R.; Coyle, V. M.; Mcart, D.; Murray, G. I.; Samuel, L.; Nuciforo, P.; Jimenez, J.; Argiles, G.; Dienstmann, R.; Tabernero, J.; Picariello, L.; Messerini, L.; Nobili, S.; Mini, E.; Sheahan, K.; Ryan, E.; Johnston, P. G.; Van Schaeybroeck, S.; Lawler, M.; Longley, D. B.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Specific markers, micro-environmental anomalies and tropism: opportunities for gold nanorods targeting of tumors in laser-induced hyperthermia | 2014 | Tatini, F.; Ratto, F.; Centi, S.; Landini, I.; Nobili, S.; Witort, E.; Fusi, F.; Capaccioli, S.; Mini, E.; Pini, R. | |
| Druggable targets in pancreatic adenocarcinoma | 2014 | Nobili, S.; Tassi, R.; Landini, I.; Perrone, G.; Napoli, C.; Mini, E. | |
| In vitro study on the safety of near infrared laser therapy in its potential application as postmastectomy lymphedema treatment | 2015 | Cialdai, F.; Landini, I.; Capaccioli, S.; Nobili, S.; Mini, E.; Lulli, M.; Monici, M. | |
| Emerging drugs in refractory colorectal cancer | 2015 | Nobili, S.; Galletta, A.; Brugia, M.; Tassi, R.; Petreni, P.; Landini, I.; Mini, E. | |
| Editorial: Multidrug resistance in cancer: Pharmacological strategies from basic research to clinical issues | 2015 | Riganti, C.; Mini, E.; Nobili, S. | |
| Chronic inflammation in urothelial bladder cancer | 2015 | Nesi, G.; Nobili, S.; Cai, T.; Caini, S.; Santi, R. | |
| MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin | 2015 | Cecchin, E.; Perrone, G.; Nobili, S.; Polesel, J.; De Mattia, E.; Zanusso, C.; Petreni, P.; Lonardi, S.; Pella, N.; D'Andrea, M.; Errante, D.; Rizzolio, F.; Mazzei, T.; Landini, I.; Mini, E.; Toffoli, G. | |
| Proteomic analysis of the cytotoxic effects induced by the organogold(iii) complex Aubipyc in cisplatin-resistant A2780 ovarian cancer cells: further evidence for the glycolytic pathway implication | 2015 | Gamberi, T.; Magherini, F.; Fiaschi, T.; Landini, I.; Massai, L.; Valocchia, E.; Bianchi, L.; Bini, L.; Gabbiani, C.; Nobili, S.; Mini, E.; Messori, L.; Modesti, A. | |
| Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines | 2015 | Toffoli, G.; Giodini, L.; Buonadonna, A.; Berretta, M.; De Paoli, A.; Scalone, S.; Miolo, G.; Mini, E.; Nobili, S.; Lonardi, S.; Pella, N.; Lo Re, G.; Montico, M.; Roncato, R.; Dreussi, E.; Gagno, S.; Cecchin, E. | |
| HLA-G 3'UTR polymorphisms impact the prognosis of stage II-III CRC patients in fluoropyrimidine-based treatment | 2015 | Garziera, M.; Bidoli, E.; Cecchin, E.; Mini, E.; Nobili, S.; Lonardi, S.; Buonadonna, A.; Errante, D.; Pella, N.; D'Andrea, M.; De Marchi, F.; De Paoli, A.; Zanusso, C.; De Mattia, E.; Tassi, R.; Toffoli, G. | |
| Association of the HLA-G 3′UTR polymorphisms with colorectal cancer in Italy: A first insight | 2016 | Garziera, M.; Catamo, E.; Crovella, S.; Montico, M.; Cecchin, E.; Lonardi, S.; Mini, E.; Nobili, S.; Romanato, L.; Toffoli, G. | |
| The inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on growth in human tumor cell lines with defective DNA damage response pathways | 2017 | Mini, E.; Landini, I.; Lucarini, L.; Lapucci, A.; Napoli, C.; Perrone, G.; Tassi, R.; Masini, E.; Moroni, F.; Nobili, S. | |
| Selection and characterization of a human ovarian cancer cell line resistant to auranofin | 2017 | Landini, I.; Lapucci, A.; Pratesi, A.; Massai, L.; Napoli, C.; Perrone, G.; Pinzani, P.; Messori, L.; Mini, E.; Nobili, S. | |
| DPYD gene activity score (GAS) predicts dose-limiting toxicity in fluoropyrimidine-treated colorectal cancer patients | 2018 | Dalle Fratte, Chiara; Polesel, Jerry; Roncato, Rossana; De Mattia, Elena; Ecca, Fabrizio; Bignucolo, Alessia; Garziera, Marica; Dreussi, Eva; Palazzari, Elisa; Buonadonna, Angela; Guardascione, Michela; Berretta, Massimiliano; Foltran, Luisa; Sartor, Franca; D’Andrea, Mario; Favaretto, Adolfo; Mini, Enrico; Nobili, Stefania; De Paoli, Antonino; Toffoli, Giuseppe; Cecchin, Erika | |
| A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis | 2018 | Lavacchi, D.; Nobili, S.; Brugia, M.; Paderi, A.; Fancelli, S.; Caliman, E.; Vergoni, F.; Mini, E. | |
| Snail immunohistochemical overexpression correlates to recurrence risk in non-muscle invasive bladder cancer: results from a longitudinal cohort study | 2018 | Santi, R.; Cai, T.; Nobili, S.; Galli, I. C.; Amorosi, A.; Comperat, E.; Nesi, G. | |
| The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice | 2018 | Toffoli, Giuseppe; Innocenti, Federico; Polesel, Jerry; De Mattia, Elena; Sartor, Franca; Dalle Fratte, Chiara; Ecca, Fabrizio; Dreussi, Eva; Palazzari, Elisa; Guardascione, Michela; Buonadonna, Angela; Foltran, Luisa; Garziera, Marica; Bignucolo, Alessia; Nobili, Stefania; Mini, Enrico; Favaretto, Adolfo; Berretta, Massimiliano; D'Andrea, Mario; De Paoli, Antonino; Roncato, Rossana; Cecchin, Erika | |
| Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study | 2018 | Magherini, F.; Fiaschi, T.; Valocchia, E.; Becatti, M.; Pratesi, A.; Marzo, T.; Massai, L.; Gabbiani, C.; Landini, I.; Nobili, S.; Mini, E.; Messori, L.; Modesti, A.; Gamberi, T. | |
| A clinical-genetic score to identify surgically resected colorectal cancer patients benefiting from an adjuvant fluoropyrimidine-based therapy | 2018 | De Mattia, E.; Dreussi, E.; Montico, M.; Gagno, S.; Zanusso, C.; Quartuccio, L.; De Vita, S.; Guardascione, M.; Buonadonna, A.; D'Andrea, M.; Pella, N.; Favaretto, A.; Mini, E.; Nobili, S.; Romanato, L.; Cecchin, E.; Toffoli, G. | |
| Transcriptional subtyping and CD8 immunohistochemistry identifies patients with stage II and III colorectal cancer with poor prognosis who benefit from adjuvant chemotherapy | 2018 | Allen, W. L.; Dunne, P. D.; Mcdade, S.; Scanlon, E.; Loughrey, M.; Coleman, H. G.; Mccann, C.; Mclaughlin, K.; Nemeth, Z.; Syed, N. A.; Jithesh, P. V.; Arthur, K.; Wilson, R.; Coyle, V. M.; Mcart, D.; Murray, G. I.; Samuel, L.; Nuciforo, P.; Jimenez, J.; Argiles, G.; Dienstmann, R.; Tabernero, J.; Picariello, L.; Messerini, L.; Nobili, S.; Mini, E.; Sheahan, K.; Ryan, E.; Johnston, P. G.; Van Schaeybroeck, S.; Lawler, M.; Longley, D. B. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile